WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+9.42%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$11.8B
AUM Growth
+$1.41B
(+13%)
Cap. Flow
+$896M
Cap. Flow
% of AUM
7.57%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
744
New
202
Increased
220
Reduced
152
Closed
160
Top Buys
| 1 |
ASML
ASML
|
$125M |
| 2 |
Meta Platforms (Facebook)
META
|
$100M |
| 3 |
STMicroelectronics
STM
|
$92.5M |
| 4 |
MetLife
MET
|
$79.4M |
| 5 |
Gilead Sciences
GILD
|
$77.3M |
Top Sells
| 1 |
TE Connectivity
TEL
|
$161M |
| 2 |
Eli Lilly
LLY
|
$151M |
| 3 |
Marsh & McLennan
MMC
|
$123M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$86.7M |
| 5 |
Electronic Arts
EA
|
$78.6M |
Sector Composition
| 1 | Healthcare | 43.57% |
| 2 | Technology | 17.47% |
| 3 | Industrials | 8.1% |
| 4 | Energy | 6.42% |
| 5 | Financials | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Replimune Group
REPL
$494M
| $3.65M | 0.03% |
332,943
+39,321
| +13% | +$431K |
|
427
Astera Labs
ALAB
$31.8B
| $3.64M | 0.03% |
69,396
+2,934
| +4% | +$154K |
|
428
Cross Country Healthcare
CCRN
$462M
| $3.53M | 0.03% |
+262,603
| New | +$3.53M |
|
429
Neurogene
NGNE
$285M
| $3.49M | 0.03% |
+83,088
| New | +$3.49M |
|
|
OTLY
430
Oatly Group
OTLY
$524M
| $3.41M | 0.03% |
199,546
+70,125
| +54% | +$1.2M |
|
431
Hain Celestial
HAIN
$164M
| $3.34M | 0.03% |
+387,137
| New | +$3.34M |
|
432
National Vision
EYE
$1.86B
| $3.26M | 0.03% |
+299,031
| New | +$3.26M |
|
|
CMPS
433
Compass Pathways
CMPS
$493M
| $3.24M | 0.03% |
+514,418
| New | +$3.24M |
|
434
EyePoint Pharmaceuticals
EYPT
$966M
| $3.2M | 0.03% |
+400,000
| New | +$3.2M |
|
435
Carlisle Companies
CSL
$16.9B
| $3.15M | 0.03% |
7,013
-10,016
| -59% | -$4.5M |
|
436
Editas Medicine
EDIT
$248M
| $3.07M | 0.03% |
900,421
-70,070
| -7% | -$239K |
|
|
ATYR
437
aTyr Pharma
ATYR
$550M
| $2.96M | 0.03% |
1,683,549
+387
| +0% | +$681 |
|
438
TAL Education Group
TAL
$6.17B
| $2.88M | 0.02% |
+243,063
| New | +$2.88M |
|
439
CrowdStrike
CRWD
$105B
| $2.88M | 0.02% |
+10,258
| New | +$2.88M |
|
440
Sana Biotechnology
SANA
$752M
| $2.86M | 0.02% |
687,821
+3,627
| +0.5% | +$15.1K |
|
441
Nkarta
NKTX
$161M
| $2.84M | 0.02% |
629,358
+1,229
| +0.2% | +$5.56K |
|
442
ArriVent BioPharma
AVBP
$819M
| $2.84M | 0.02% |
120,944
+20,944
| +21% | +$492K |
|
443
Kura Oncology
KURA
$713M
| $2.8M | 0.02% |
143,207
| – | – |
|
444
Context Therapeutics
CNTX
$73.6M
| $2.67M | 0.02% |
+1,360,682
| New | +$2.67M |
|
445
Western Digital
WDC
$31.9B
| $2.66M | 0.02% |
51,475
-463,878
| -90% | -$23.9M |
|
|
BIOA
446
BioAge Labs, Inc. Common Stock
BIOA
$171M
| $2.6M | 0.02% |
+124,950
| New | +$2.6M |
|
447
Arbutus Biopharma
ABUS
$805M
| $2.57M | 0.02% |
668,153
-258,381
| -28% | -$995K |
|
448
Fabrinet
FN
$13.2B
| $2.57M | 0.02% |
+10,864
| New | +$2.57M |
|
449
Xoma
XOMA
$426M
| $2.52M | 0.02% |
95,339
+23,128
| +32% | +$612K |
|
450
Playtika
PLTK
$1.4B
| $2.52M | 0.02% |
+318,208
| New | +$2.52M |
|